Vioxx Class Action Update-November 13, 2007

On November 9, 2007, Merck & Co., Inc. announced that it entered into an agreement with several law firms of the Plaintiffs’ Steering Committee of the federal multi-district Vioxx litigation as well as representatives of plaintiffs’ counsel in numerous state proceedings to resolve certain claims filed against Merck in the United States.

The agreement contains certain conditions that must be met in order for the settlement funds to be paid by Merck. The settlement is not a class-action settlement but rather each claim must be evaluated on an individual basis in order to determine if the criteria have been met.

It is important to note that this settlement applies to American residents only and has no impact on any class-action lawsuits filed in Canada or on Canadian residents. It is, however, a positive development.

If you believe you have a potential claim against the makers of Vioxx, please contact our office immediately at (204) 947-1456 or toll free at 1-888-470-0847 or fill out the form entitled “Questionnaire for Potential Claimants” on this website by first clicking “Vioxx”.

For those who have already contacted our office, please note that we will be posting updates on this website from time to time to ensure that you have up to date information regarding the case. If you have questions that cannot be answered by reading the materials on this website, please contact us at (204) 947-1456 or email us at:

swilder@wilderwilder.com
mmaruca@wilderwilder.com